Literature DB >> 4020636

Contribution of the lung to total body clearance of meperidine in the dog.

W G Kramer, D R Gross, C Medlock.   

Abstract

The potential role of the lung in the disposition of meperidine was examined in six conscious dogs instrumented for measurement of appropriate hemodynamic parameters. Following an intravenous bolus injection of 5 mg/kg, blood samples were collected simultaneously from cannulas placed in the left ventricle and the pulmonary artery, concurrent with the hemodynamic measurements. Pulmonary clearance, calculated from concentration differences between pulmonary arterial and left ventricular blood and pulmonary blood flow, averaged 12.1 +/- 3.70 mL/min/kg, accounting for 58 +/- 13% of the total clearance of the drug. These results help resolve differences between previously reported meperidine clearance in the dog and physiological blood flows and imply that the dog may be a poor model for this drug in humans where clearance is primarily hepatic.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4020636     DOI: 10.1002/jps.2600740517

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Pulmonary disposition of pethidine in postoperative patients.

Authors:  M P Persson; P Hartvig; L Wiklund; L Paalzow
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

2.  Analysis of arterial-venous blood concentration difference of drugs based on recirculatory theory with fast inverse Laplace transform (FILT).

Authors:  Y Yano; K Yamaoka; H Yasui; T Nakagawa
Journal:  J Pharmacokinet Biopharm       Date:  1991-02

3.  Reduction and lumping of physiologically based pharmacokinetic models: prediction of the disposition of fentanyl and pethidine in humans by successively simplified models.

Authors:  Sven Björkman
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-08       Impact factor: 2.745

4.  Analysis of pethidine disposition in the pregnant rat by means of a physiological flow model.

Authors:  J L Gabrielsson; P Johansson; U Bondesson; M Karlsson; L K Paalzow
Journal:  J Pharmacokinet Biopharm       Date:  1986-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.